Alchemab Therapeutics

Alchemab Therapeutics focuses on developing antibody therapeutics for difficult-to-treat diseases by studying resilient individuals to understand how they overcome these diseases.
  • Drug discovery
  • Clinical development
  • Antibody therapeutics
  • Target identification
Size
Small
Phone
N/A
Website
alchemab.com
Email
N/A
Locations
East Side, Office 1.02, N1C 4AX
1, Lion Works, Station Rd E, CB22 4WL
55-56 Russell Sq, WC1B 4HP
Digital Popularity
Social Media
Competitors
Exscientia
Exscientia is a technology-driven company focused on AI drug discovery, aiming to revolutionise the pharmaceutical industry through precision medicine.
Company Details
Alchemab Therapeutics is operated by Alchemab Therapeutics Ltd and is a Active company incorporated on 14 August 2019 with the registered office located in London, Greater London. Alchemab Therapeutics Ltd was registered 6 years ago.
Status
Active
Size
Unreported
Directors
6
Age
6 years old
Employees
60
Turnover
£1.59M
Total Assets
£22.44M
Cash in Bank
£15.58M
Total Liabilities
-£31.77M
John Hamer
Director • American • Lives in United States • Born in Dec 1957
Dame Catherine Elizabeth Bingham
Director • British • Lives in UK • Born in Oct 1965
Andrew David Levin
Director • American • Lives in United States • Born in Nov 1976
Mr Young T. Kwon
Director • Chief Executive Officer • American • Lives in United States • Born in Jan 1972
Kevin Lee
Director • English • Lives in England • Born in Apr 1968
Jane Katharine Osbourn
Director • British • Lives in England • Born in Mar 1966
More information on Alchemab Therapeutics Ltd
Teams
All
45
Management
29
Research
19
IT
5
Other
5
Alexander Hewitson
Vice President • Joined Feb 2022
Malcolm Gates
Vice President Of Finance • Joined Dec 2024
Jacob Galson
Vice President Of Technology • Joined Jul 2023
Paul Varley
Senior Vice President Development • Joined Sep 2021
Ralph Minter
Senior Vice President Of Rsearch • Joined Sep 2023
Jane Osbourn Obe
Chief Executive Officer • Joined Sep 2024
Rachael Bashford-Rogers
Co-founder • Joined Oct 2019
Katarzyna Kmiecik
Principal Scientist • Joined Jan 2025
David Yadin
Principal Scientist • Joined Jan 2023
Laura Mitchell
Principal Bioinformatician • Joined Jan 2023
Alexander Hewitson
Vice President • Joined Feb 2022
Malcolm Gates
Vice President Of Finance • Joined Dec 2024
Jacob Galson
Vice President Of Technology • Joined Jul 2023
Paul Varley
Senior Vice President Development • Joined Sep 2021
Jane Osbourn Obe
Chief Executive Officer • Joined Sep 2024
Rachael Bashford-Rogers
Co-founder • Joined Oct 2019
Katarzyna Kmiecik
Principal Scientist • Joined Jan 2025
David Yadin
Principal Scientist • Joined Jan 2023
Laura Mitchell
Principal Bioinformatician • Joined Jan 2023
Matthew Kraman
Principal Scientist • Joined Sep 2020
Katarzyna Kmiecik
Principal Scientist • Joined Jan 2025
David Yadin
Principal Scientist • Joined Jan 2023
Matthew Kraman
Principal Scientist • Joined Sep 2020
Paulina Kolasinska-Zwierz
Principal Scientist • Joined Jan 2023
Helen Graves
Principal Scientist • Joined Jul 2021
Jorge Dias
Principal Scientist • Joined Jul 2021
Francesca Nice
Senior Scientist • Joined May 2021
Anna Czyz
Protein Scientist • Joined Sep 2021
William Hawthorne
Scientist • Joined Apr 2022
Sofia Romano
Senior Scientist • Joined Jun 2022
Jacob Galson
Vice President Of Technology • Joined Jul 2023
Raul Tamas
Information Technology Support Team Lead • Joined Sep 2022
Eduard Talpos
IT Support Technician • Joined Jul 2022
Jessica Ginn
Software Engineer • Joined Jan 2025
Harold Davin
Information Technology Support Engineer • Joined Oct 2023
Ralph Minter
Senior Vice President Of Rsearch • Joined Sep 2023
Olivia Cavlan
Chief Corporate Development And Strategy Officer • Joined Jan 2022
Matthew Kraman
Associate Director Of Immunology • Joined Jul 2022
Donna Finch
Head Of Translational And Clinical Sciences • Joined Apr 2020
Amparo Toboso Navasa
Bioinformatician, Antibody Discovery And Target Deconvolution • Joined Oct 2021
View 45 members